284 related articles for article (PubMed ID: 29778513)
1. The immune response of rhesus macaques to novel vaccines comprising hepatitis B virus S, PreS1, and Core antigens.
Chuai X; Xie B; Chen H; Tan X; Wang W; Huang B; Deng Y; Li W; Tan W
Vaccine; 2018 Jun; 36(26):3740-3746. PubMed ID: 29778513
[TBL] [Abstract][Full Text] [Related]
2. Recombinant vaccinia vector-based vaccine (Tiantan) boosting a novel HBV subunit vaccine induced more robust and lasting immunity in rhesus macaques.
Deng Y; Chuai X; Chen P; Chen H; Wang W; Ruan L; Li W; Tan W
Vaccine; 2017 Jun; 35(25):3347-3353. PubMed ID: 28487055
[TBL] [Abstract][Full Text] [Related]
3. Protective efficacy and hepatitis B virus clearance in mice enhanced by cell-mediated immunity with novel prime-boost regimens.
Chuai X; Chen P; Chen H; Wang W; Deng Y; Ruan L; Li W; Tan W
J Viral Hepat; 2017 Apr; 24(4):337-345. PubMed ID: 27885748
[TBL] [Abstract][Full Text] [Related]
4. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
[TBL] [Abstract][Full Text] [Related]
5. [Boosting with HBV subunit particle vaccine enhance immune response of novel DNA vaccine consisting of S-PreS1 fusion gene in mice].
Chen H; Deng Y; Tan W; Wang W; Guan J; Wen B; Yin X; Ruan L
Sheng Wu Gong Cheng Xue Bao; 2011 Jan; 27(1):95-100. PubMed ID: 21553495
[TBL] [Abstract][Full Text] [Related]
6. Recombinant hepatitis B core antigen carrying preS1 epitopes induce immune response against chronic HBV infection.
Chen X; Li M; Le X; Ma W; Zhou B
Vaccine; 2004 Jan; 22(3-4):439-46. PubMed ID: 14670326
[TBL] [Abstract][Full Text] [Related]
7. Optimisation of prime-boost immunization in mice using novel protein-based and recombinant vaccinia (Tiantan)-based HBV vaccine.
Chen H; Chuai X; Deng Y; Wen B; Wang W; Xiong S; Ruan L; Tan W
PLoS One; 2012; 7(9):e43730. PubMed ID: 22970140
[TBL] [Abstract][Full Text] [Related]
8. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS
World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132
[TBL] [Abstract][Full Text] [Related]
9. Poly(I:C)/alum mixed adjuvant priming enhances HBV subunit vaccine-induced immunity in mice when combined with recombinant adenoviral-based HBV vaccine boosting.
Chuai X; Chen H; Wang W; Deng Y; Wen B; Ruan L; Tan W
PLoS One; 2013; 8(1):e54126. PubMed ID: 23335993
[TBL] [Abstract][Full Text] [Related]
10. DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques.
Obeng-Adjei N; Hutnick NA; Yan J; Chu JS; Myles DJ; Morrow MP; Sardesai NY; Weiner DB
Cancer Gene Ther; 2013 Dec; 20(12):652-62. PubMed ID: 24310062
[TBL] [Abstract][Full Text] [Related]
11. Enhanced effect of DNA immunization plus in vivo electroporation with a combination of hepatitis B virus core-PreS1 and S-PreS1 plasmids.
Chen H; Wen B; Deng Y; Wang W; Yin X; Guan J; Ruan L; Tan W
Clin Vaccine Immunol; 2011 Nov; 18(11):1789-95. PubMed ID: 21900535
[TBL] [Abstract][Full Text] [Related]
12. HBV antigen and DNA loss from mouse serum is associated with novel vaccine-induced HBV surface antigen-specific cell-mediated immunity and cytokine production.
Chuai X; Xie B; Deng Y; Zhao Y; Wang W; Gao Z; Wang W; Qiu X; Tan W
Antiviral Res; 2019 Jan; 161():20-27. PubMed ID: 30423362
[TBL] [Abstract][Full Text] [Related]
13. [Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].
Chen H; Deng Y; Tan W; Wang W; Yin X; Guan J; Wang W; Ruan L
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):74-8. PubMed ID: 20353095
[TBL] [Abstract][Full Text] [Related]
14. Nasal route favors the induction of CD4
Bourgine M; Crabe S; Lobaina Y; Guillen G; Aguilar JC; Michel ML
Antiviral Res; 2018 May; 153():23-32. PubMed ID: 29510155
[TBL] [Abstract][Full Text] [Related]
15. [Immunological and virological efficacy against HBV chronic infection of the therapeutic vaccine composed of HBV core plus PreS1 in HBV transgenic mice].
Li MZ; Chen XC; Zhou BP; Le XH; Xu LM; Wang HS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):277-9. PubMed ID: 15340577
[TBL] [Abstract][Full Text] [Related]
16. A novel chimeric Hepatitis B virus S/preS1 antigen produced in mammalian and plant cells elicits stronger humoral and cellular immune response than the standard vaccine-constituent, S protein.
Dobrica MO; Lazar C; Paruch L; Skomedal H; Steen H; Haugslien S; Tucureanu C; Caras I; Onu A; Ciulean S; Branzan A; Clarke JL; Stavaru C; Branza-Nichita N
Antiviral Res; 2017 Aug; 144():256-265. PubMed ID: 28666757
[TBL] [Abstract][Full Text] [Related]
17. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
[TBL] [Abstract][Full Text] [Related]
18. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
[TBL] [Abstract][Full Text] [Related]
19. A bi-functional hepatitis B virus core antigen (HBcAg) chimera activates HBcAg-specific T cells and preS1-specific antibodies.
Malik IR; Chen A; Brass A; Ahlén G; Rahman M; Sällberg M; Qureshi JA; Frelin L
Scand J Infect Dis; 2012 Jan; 44(1):55-9. PubMed ID: 21933033
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of a chimeric Hepatitis B Virus S/preS1 antigen produced in lettuce triggers infection neutralizing antibodies in mice.
Dobrica MO; Lazar C; Paruch L; van Eerde A; Clarke JL; Tucureanu C; Caras I; Ciulean S; Onu A; Tofan V; Branzan A; Urban S; Stavaru C; Branza-Nichita N
Vaccine; 2018 Sep; 36(38):5789-5795. PubMed ID: 30082163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
